Arrowhead Research
ARWR
97 hedge funds and large institutions have $220M invested in Arrowhead Research in 2016 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 19 reducing their positions, and 9 closing their positions.
111% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 19
101% more capital invested
Capital invested by funds: $110M → $220M (+$111M)
100% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 9
10% more funds holding
Funds holding: 88 → 97 (+9)
33% less call options, than puts
Call options by funds: $2.79M | Put options by funds: $4.17M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$14M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$9.89M |
| 3 |
RI
RTW Investments
New York
|
+$7.24M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
+$5.49M |
| 5 |
PA
Perceptive Advisors
New York
|
+$5.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.6M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.19M |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$393K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$292K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$285K |
ARWR Hedge Fund Activity: Q3 2016 in Review
97 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Arrowhead Research (ARWR) for Q3 2016, worth a combined $220M — up 101% from $110M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new ARWR positions and 9 closed out — a net gain of 9 holders — while 40 added to existing stakes and 19 trimmed.
The largest buyer was OrbiMed, opening a new position worth an estimated $14M. The largest seller was Point72 Asset Management, cutting an estimated $1.6M.
- 97 institutional investors held Arrowhead Research (ARWR) as of Q3 2016, up from 88 in Q2 2016.
- Funds reported $220M of Arrowhead Research stock for Q3 2016, up 101% quarter-over-quarter.
- 18 funds opened new Arrowhead Research positions in Q3 2016 and 9 closed out, a net change of +9 holders.
- The largest Arrowhead Research buyer in Q3 2016 was OrbiMed, an estimated $14M added.
- The largest Arrowhead Research seller in Q3 2016 was Point72 Asset Management, an estimated $1.6M sold.
Based on aggregated 13F filings for Q3 2016.